Trial Profile

A Phase IIa Non-Blinded Study of Safety, Tolerability and Efficacy of S1B-408 in Women With Orgasmic Dysfunction

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 06 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs S1B 408 (Primary)
Indications Anorgasmia
Focus Therapeutic Use
Sponsors S1 Biopharma

Most Recent Events

27 Apr 2025 Planned number of patients changed from 20 to 30.
27 Apr 2025 Planned End Date changed from 30 Jul 2025 to 30 Mar 2027.
27 Apr 2025 Planned primary completion date changed from 25 Jun 2025 to 30 Dec 2026.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com